A Study of Cognitive Health in Survivors of Prostate Cancer

Memorial Sloan Kettering Cancer Center (MSK)

Status: Active, not recruiting

Conditions: Survivorship; Prostate Cancer

Treatments: Behavioral: PROMIS-SF v2.0 -Cognitive Function 8a

Study type: Observational

Funder types: Other

Identifiers

NCT05540782

22-223

Details and patient eligibility

About

The purpose of this study is to collect information that may help the researchers understand the relationship between prostate cancer survivors' experiences of cancer-related cognitive dysfunction (CRCD) and their other conditions (co-morbid factors), including anxiety, depression, and insomnia. The researchers will also find out how additional things may contribute to CRCD, including social factors, the characteristics of participants' prostate cancer, and the type of cancer treatment or other medications they received.

Enrollment: 200 patients

Sex: Male

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• English-speaking
• Age 18 years or older
• History of histologically documented PC of any stage
• No evidence of PC Disease

Exclusion criteria

• <1 month since completion of surgery, radiation, chemotherapy, or ADT
• Diagnosis of Alzheimer's disease, vascular dementia, Parkinson disease, or other organic brain disorder
• Score >10 indicative of dementia on Blessed Orientation Memory Concentration

Trial design

200 participants in 1 patient group

Survivors of Prostate Cancer

Description:

This is a cross-sectional study with a one-time data collection process and no subsequent follow-ups. If patients did not opt out of receiving study-specific text communications, they may also receive text messages with reminders about surveys and/or direct links to REDCap to complete the surveys. Text-based communications will be delivered using the secure, HIPAA-compliant Mosio texting platform developed for clinical research.

Treatment:

Behavioral: PROMIS-SF v2.0 -Cognitive Function 8a